Mice bearing HCC827 (human NSCLC) and HCC827ErlRes (erlotinib resistant human NSCLC with c‐Met upregulation) tumors went through 89Zr‐onartuzumab PET scans. This evidence concerns the gene MET and non-small cell lung carcinoma.